BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 307723)

  • 1. [Antibody dependent cell-bound cytotoxicity in systemic lupus erythematosus].
    Láng I; Fekete B; Török K; Pálóczi K; Sonkoly I; Szegedi G; Gergely P
    Orv Hetil; 1978 Jul; 119(31):1885-7. PubMed ID: 307723
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
    Scheinberg MA; Cathcart ES
    Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent cellular cytotoxicity in systemic lupus erythematosus.
    Láng I; Fekete B; Pálóczi K; Sonkoly I; Szegedi G; Török K; Gergely P; Petrányi G
    Acta Med Acad Sci Hung; 1977; 34(4):259-65. PubMed ID: 618057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytotoxicity of human lymphocytes induced by antibody: response in patients with systemic lupus erythematosus and effect of immunosuppressive treatment].
    Manni JA; de Bracco MM; Patrucco A
    Medicina (B Aires); 1974; 34(3):185-93. PubMed ID: 4547009
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
    Messner RP; Lindström FD; Williams RC
    J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active disease.
    Tsokos GC; Balow JE
    J Clin Lab Immunol; 1982 Jun; 8(2):83-90. PubMed ID: 6213778
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus.
    Penning CA; French MA; Rowell NR; Hughes P
    J Clin Lab Immunol; 1985 Jul; 17(3):125-30. PubMed ID: 3876447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis.
    Cooper SM; Harding B; Mirick GR; Schneider J; Quismorio FP; Friou GJ
    Clin Exp Immunol; 1978 Nov; 34(2):235-40. PubMed ID: 737908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte adhesive properties in systemic lupus erythematosus].
    Isaeva LA; Levina SG; Geppe NA; Kuznetsov SL; Snesarevskaia IP
    Sov Med; 1980; (9):39-43. PubMed ID: 6158760
    [No Abstract]   [Full Text] [Related]  

  • 10. T and B lymphocytes in systemic lupus erythematosus.
    Massuda HK; Rocha Ferreira GG; Bernhardsgruter B; Oliveira Lima A; Sette Camara DC
    Rev Bras Pesqui Med Biol; 1974; 7(3):279-81. PubMed ID: 4138198
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autoantibodies in systemic erythematosis. I. Incidence of antibodies against the CEM T-lymphocyte line].
    Jíra M; Strejcek J; Antosová E; Rejholec V; Singerová D; Zavadil Z
    Vnitr Lek; 1988 Nov; 34(11):1062-8. PubMed ID: 3264641
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies for T lymphocytes in systemic lupus erythematosus.
    Michlmayr G; Pathouli C; Huber C; Huber H
    Clin Exp Immunol; 1976 Apr; 24(1):18-25. PubMed ID: 1084815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    Miller ML; Lantner R; Pachman LM
    J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the peripheral blood lymphocytes in systemic lupus erythematosus of different degree of activity].
    Bulanova TD; Speranskiĭ AI; Gordovskaia NB; Ivanova MM
    Ter Arkh; 1978; 50(9):94-8. PubMed ID: 309188
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody dependent cellular cytotoxicity of lymphocytes in patients with renal diseases of immunopathological origin.
    Láng I; Kenéz B; Nagy ZK; Sonkoly I; Pálóczi K; Szegedi G; Fekete B; Gergely P
    Clin Nephrol; 1978 Mar; 9(3):111-4. PubMed ID: 565267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab: a promising therapy in systemic lupus erythematosus.
    Thatayatikom A; White AJ
    Autoimmun Rev; 2006 Jan; 5(1):18-24. PubMed ID: 16338207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interrelationships of cellular and humoral immunity indices in systemic lupus erythematosus].
    Matveĭkov GP; Dosin IuM; Kaliia ES; Koshelev VK; Nazarov IuM
    Ter Arkh; 1982; 54(12):44-8. PubMed ID: 6984235
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic lupus erythematosus--an autoimmune disease?
    Holborow EJ
    J Clin Pathol Suppl (R Coll Pathol); 1978; 12():144-9. PubMed ID: 365887
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI
    Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surface markers of peripheral blood T- and B-lymphocytes in patients with rheumatoid diseases].
    Stankaitene DI; Redaitene EI; Rulis AK; Ianulevichiute NA
    Ter Arkh; 1981; 53(7):6-11. PubMed ID: 7027511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.